Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $112.60M | $88.67M | 43.00% | -$23.93M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 4,120,053 | +4,120,053 | $0 | $45.36M | 22.00% | +$45.36M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $66.15M | $37.55M | 18.21% | -$28.60M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $27.75M | $15.15M | 7.34% | -$12.60M |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $11.33M | $9.12M | 4.42% | -$2.21M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $7.29M | $8.78M | 4.26% | +$1.49M |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $981.1K | $1.05M | 0.51% | +$63.9K |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $1.10M | $532.0K | 0.26% | -$570.5K |
| CERo Therapeutics Holdings, Inc.(CERO) | 0 | 22,102 | +22,102 | $0 | $16.1K | 0.01% | +$16.1K |
| Singular Genomics Systems, Inc. | 126,630 | 0 | -126,630 | $2.46M | $0 | — | -$2.46M |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 9,393,561 | 0 | -9,393,561 | $563.6K | $0 | — | -$563.6K |